The master transcription factor ASCL1 is indispensable for pulmonary neuroendocrine cell differentiation [8, 9], and targeted disruption of Ascl1 has been shown to abrogate tumour formation in a mouse model of SCLC [10]. Here, ASCL1 is linked to small cell lung carcinoma.